Ghost Tree Capital’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-90,000
| Closed | -$2.13M | – | 76 |
|
|
2023
Q4 | $2.13M | Buy |
+90,000
| New | +$2.13M | 0.7% | 34 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 74 |
|
|
2019
Q4 | – | Sell |
-440,000
| Closed | -$2.25M | – | 57 |
|
|
2019
Q3 | $2.25M | Sell |
440,000
-560,000
| -56% | -$2.87M | 0.57% | 34 |
|
|
2019
Q2 | $7.16M | Buy |
1,000,000
+250,000
| +33% | +$1.79M | 1.49% | 15 |
|
|
2019
Q1 | $9.96M | Buy |
+750,000
| New | +$9.96M | 2.6% | 15 |
|
|
2017
Q3 | – | Sell |
-650,000
| Closed | -$3.74M | – | 64 |
|
|
2017
Q2 | $3.74M | Buy |
650,000
+150,000
| +30% | +$864K | 0.78% | 38 |
|
|
2017
Q1 | $2.15M | Buy |
+500,000
| New | +$2.15M | 0.4% | 46 |
|
|
2015
Q4 | – | Sell |
-400,000
| Closed | -$776K | – | 70 |
|
|
2015
Q3 | $776K | Buy |
+400,000
| New | +$776K | 0.35% | 56 |
|